Epitope discovery technology to advance vaccine and immunotherapy design
Epitope discovery technology to advance vaccine and immunotherapy design Beckman Coulter
Beckman Coulter’s iTopia® Epitope Discovery System helps researchers advance important candidates quickly through the development process. It facilitates peptide identification and ranking based on binding characterization, along with assisting in the selection of individual populations most likely to respond. This may improve the productivity of clinical trials and can form the basis for an immune monitoring system to follow individuals.
For Research Use Only. Not for use in diagnostic procedures.